상단영역

본문영역

  • 기자명 Jung Hyun Ko
  • Health & Life
  • Published 2021.09.27 05:35

[Pangyo Bio & Medical]SK Bioscience holds mRNA Vaccine Patent Analysis Briefing Session

The Korean Intellectual Property Office (KIPO) held “mRNA Vaccine Patent Analysis Briefing Session” at SK Bioscience, a vaccine developer located in Seongnam, Gyeonggi Province, on Sep. 9.

At the briefing session, major technologies by mRNA vaccine production processes, key patents, examples, and disputes were announced, and shared patent issues by production processes when developing and producing mRNA platform-based COVID-19 vaccine.

In addition to the mRNA patent analysis, the results of patent analysis on non-mRNA vaccines and raw materials were also introduced.

Following the briefing, KIPO Deputy Director Kim Yong-sun had a meeting with SK Bioscience President Ahn Jae-yong and other relevant officials to listen to the difficulties related to intellectual property rights during the vaccine development stage, and took a tour around the vaccine R&D site.

President Ahn said, "If we utilize the results of this mRNA patent analysis, it would be greatly helpful in determining the direction of future vaccine research and development."

Deputy Director Kim said, "We will do everything we can to provide policy support so that Korea can be vaccine-independent and furthermore become the global hub to supply the vaccine to the world.”

Pangyo Technovalley is an innovation hub for global companies comparable to the Silicon Valley in the US, Zhongguancun in China, and STATION F in France. It is an Asia tech hub with 1,259 IT, BT, CT, and NT companies that possess innovative products and technologies. Located just south of the metropolitan area, it provides the best environment for Korean companies to do business with great transportation access and infrastructure.

Various high-tech companies are located in Pangyo Technovalley, and it is occupied by 64,000 full-time employees, many in their 20-30s. In terms of industry, the companies are engaged in information technology, contents technology, biotechnology, and nanotechnology.

With the support of innovative companies with global capabilities such as Kakao, Naver, AhnLab, Krafton, NCSoft, Nexon, and Hancom, companies in Pangyo Technovalley recorded 107 trillion won in sales last year. Investment and infrastructure growth in Pangyo is expected to continue, with the Metaverse hub entering Pangyo this year.

Source: Pangyo Techno Valley Official Newsroom 

→PANGYO TV

하단영역